Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c1175474f8e0a1723619a57758ee1d6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2023-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2f48099f431da16ed6f43178d6659ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab07a8ba1941b62a887f0238a4ec322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f251bd3d4a7cc4e70f8aff9b2bbecd98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d01e419011f24071a33408f8ff9dbcc |
publicationDate |
2023-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11629146-B2 |
titleOfInvention |
Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity |
abstract |
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein. |
priorityDate |
2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |